Rice University Team Develops Novel "Smart Cell" Construction Kit

Rice University bioengineers have created a new toolkit for designing custom sense-and-respond circuits in human cells, potentially advancing therapies for complex conditions like autoimmune diseases and cancer. The research, published in Science, leverages phosphorylation, a natural cellular process, to build artificial signaling pathways.

Lead author Xiaoyu Yang describes the potential: "Imagine tiny processors inside cells made of proteins that can 'decide' how to respond to specific signals like inflammation, tumor growth markers or blood sugar levels. This work brings us a whole lot closer to being able to build ‘smart cells’ that can detect signs of disease and immediately release customizable treatments in response.”

The team's innovation lies in treating each cycle in a phosphorylation cascade as an elementary unit that can be linked in novel ways. This approach allows for the construction of entirely new pathways connecting cellular inputs and outputs.

Caleb Bashor, corresponding author, explains: "Phosphorylation cycles are not just interconnected but interconnectable—this is something that we were not sure could be done with this level of sophistication before."

The synthetic circuits demonstrated rapid response times, activating within seconds or minutes, unlike previous designs based on slower processes like transcription. The researchers successfully tested the circuits' ability to respond to external signals such as inflammatory factors.

To showcase its potential, the team engineered a cellular circuit capable of detecting inflammatory factors, which could be used to control autoimmune flare-ups and reduce immunotherapy-associated toxicity.

Caroline Ajo-Franklin, director of the Rice Synthetic Biology Institute, highlights the significance: "If in the last 20 years synthetic biologists have learned how to manipulate the way bacteria gradually respond to environmental cues, the Bashor lab's work vaults us forward to a new frontier—controlling mammalian cells' immediate response to change."